why choose us

First received: March 08, 2023

Clinical Trial: A Study to Assess the Food Effect and the Relative Bioavailability of the Cabotegravir (CAB) Pediatric Dispersible Tablet (DT) Formulation

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: HIV Infections

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Single-center, Randomized, Open-label, Single Dose, Three-period, Balanced Crossover Study to Assess the Effect of Food on the Pediatric Dispersible Tablet Formulation of Cabotegravir and t

Brief Summary: This study will assess the relative bioavailability of the CAB DT formulation relative to that of the CAB IR formulation and to assess the effect of food on the CAB DT formulation.

Read more